BOSTON--(BUSINESS WIRE)--Click to Tweet
th the consumer and drug development arms of the business” Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated with severe neuromuscular conditions, and exercise-associated muscle cramps, announced today that Michelle V. Stacy, former President of Keurig Inc., has joined its Board of Directors.
th the consumer and drug development arms of the business” Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated with severe neuromuscular conditions, and exercise-associated muscle cramps, announced today that Michelle V. Stacy, former President of Keurig Inc., has joined its Board of Directors.
